2-[[4-(2-Methoxyethyl)Phenoxy]Methyl]Oxirane
- CAS No.56718-70-8
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High purity pharmaceutical intermediate designed for cardiovascular drug synthesis. Ideal for large-scale manufacturing with consistent quality assurance.
Request Bulk PricingProduct Technical Details
Product Overview
2-[[4-(2-Methoxyethyl)Phenoxy]Methyl]Oxirane, identified by CAS number 56718-70-8, is a critical organic compound utilized extensively within the pharmaceutical industry. This specialized chemical serves as a foundational building block in the synthesis of advanced therapeutic agents, particularly within the cardiovascular sector. Our manufacturing process ensures that every batch meets rigorous international standards for purity and stability, making it a reliable choice for complex organic synthesis workflows.
The molecular structure features a stable oxirane ring linked to a methoxyethyl-substituted phenoxy group. This configuration provides excellent reactivity profiles necessary for downstream chemical transformations. We prioritize consistency in production, ensuring that the physicochemical properties remain uniform across large-scale orders. This reliability is essential for manufacturers who require predictable outcomes in their multi-step synthesis routes.
Technical Specifications
Quality control is paramount in the production of pharmaceutical intermediates. Our facility employs advanced analytical techniques to verify composition and purity. The following table outlines the key physical and chemical parameters guaranteed for this product.
| Parameter | Specification |
|---|---|
| CAS Number | 56718-70-8 |
| Molecular Formula | C12H16O3 |
| Molecular Weight | 208.25 g/mol |
| Appearance | Colorless clear liquid |
| Assay (Purity) | ≥98.0% |
| Density | 1.099 g/cm3 |
| Boiling Point | 300.6°C at 760 mmHg |
Industrial Applications
This compound is primarily recognized for its role as a key intermediate in the production of beta-blockers, such as Metoprolol. The high purity level ensures minimal impurity carryover into the final active pharmaceutical ingredient (API). By utilizing our intermediate, pharmaceutical manufacturers can optimize their yield and reduce purification costs during later stages of production. It is suitable for use in regulated environments where documentation and traceability are mandatory.
Beyond specific drug synthesis, this chemical demonstrates versatility in various organic synthesis applications requiring epoxy-functionalized aromatic ethers. Researchers and process chemists value its stability under standard storage conditions and its predictable reactivity during nucleophilic ring-opening reactions. We support our clients with technical data packages that facilitate regulatory filings and process validation.
Quality Assurance and Safety
Every shipment is accompanied by a Certificate of Analysis (COA) detailing batch-specific test results. Our quality management system adheres to strict protocols to prevent contamination and ensure product integrity. Safety data sheets (SDS) are provided to guide safe handling, storage, and disposal procedures. We recommend storing the material in a cool, ventilated area away from incompatible substances to maintain its chemical stability over time.
Logistics and Packaging
We understand the importance of secure logistics in the global chemical supply chain. Standard packaging includes 25 kg drums, though we offer flexible solutions tailored to specific customer requirements. Our logistics partners ensure timely delivery while maintaining compliance with international transportation regulations for chemical goods. Contact our sales team for detailed information on bulk pricing and lead times for large-volume orders.
